Genomed Spólka Akcyjna (WSE:GEN)

Genomed Spólka Akcyjna Statistics

Total Valuation

WSE:GEN has a market cap or net worth of PLN 31.71 million. The enterprise value is 26.19 million.

Market Cap	31.71M
Enterprise Value	26.19M

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

WSE:GEN has 1.32 million shares outstanding.

Current Share Class	648,283
Shares Outstanding	1.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.76%
Owned by Institutions (%)	n/a
Float	44,349

Valuation Ratios

The trailing PE ratio is 10.32.

PE Ratio	10.32
Forward PE	n/a
PS Ratio	1.07
PB Ratio	2.25
P/TBV Ratio	2.26
P/FCF Ratio	17.06
P/OCF Ratio	9.66
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.62, with an EV/FCF ratio of 14.09.

EV / Earnings	8.53
EV / Sales	0.89
EV / EBITDA	5.62
EV / EBIT	6.78
EV / FCF	14.09

Financial Position

The company has a current ratio of 8.18

Current Ratio	8.18
Quick Ratio	6.89
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	844.72

Financial Efficiency

Return on equity (ROE) is 24.55% and return on invested capital (ROIC) is 37.46%.

Return on Equity (ROE)	24.55%
Return on Assets (ROA)	17.04%
Return on Invested Capital (ROIC)	37.46%
Return on Capital Employed (ROCE)	26.74%
Weighted Average Cost of Capital (WACC)	4.97%
Revenue Per Employee	528,265
Profits Per Employee	54,848
Employee Count	56
Asset Turnover	2.09
Inventory Turnover	5.92

Taxes

In the past 12 months, WSE:GEN has paid 763,936 in taxes.

Income Tax	763,936
Effective Tax Rate	19.92%

Stock Price Statistics

The stock price has increased by +8.33% in the last 52 weeks. The beta is 0.13, so WSE:GEN's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	+8.33%
50-Day Moving Average	24.87
200-Day Moving Average	26.48
Relative Strength Index (RSI)	39.80
Average Volume (20 Days)	48

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:GEN had revenue of PLN 29.58 million and earned 3.07 million in profits.

Revenue	29.58M
Gross Profit	19.52M
Operating Income	3.86M
Pretax Income	3.84M
Net Income	3.07M
EBITDA	4.66M
EBIT	3.86M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 5.53 million in cash and n/a in debt, with a net cash position of 5.53 million or 4.18 per share.

Cash & Cash Equivalents	5.53M
Total Debt	n/a
Net Cash	5.53M
Net Cash Per Share	4.18
Equity (Book Value)	14.07M
Book Value Per Share	n/a
Working Capital	9.72M

Cash Flow

In the last 12 months, operating cash flow was 3.28 million and capital expenditures -1.43 million, giving a free cash flow of 1.86 million.

Operating Cash Flow	3.28M
Capital Expenditures	-1.43M
Depreciation & Amortization	796,299
Net Borrowing	n/a
Free Cash Flow	1.86M
FCF Per Share	1.41

Margins

Gross margin is 65.99%, with operating and profit margins of 13.05% and 10.38%.

Gross Margin	65.99%
Operating Margin	13.05%
Pretax Margin	12.97%
Profit Margin	10.38%
EBITDA Margin	15.74%
EBIT Margin	13.05%
FCF Margin	6.28%

Dividends & Yields

WSE:GEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	9.69%
FCF Yield	5.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7